ArticleFrontiers in oncology2021
Adaptive Attention Convolutional Neural Network for Liver Tumor Segmentation.
Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Automatic Diagnosis of Hepatocellular Carcinoma and Metastases Based on Computed Tomography Images.Journal of imaging informatics in medicine · 2025Article
- Multi-Scale Convolutional Attention and Structural Re-Parameterized Residual-Based 3D U-Net for Liver and Liver Tumor Segmentation from CT.Sensors (Basel, Switzerland) · 2025Article
- Hybrid gabor attention convolution and transformer interaction network with hierarchical monitoring mechanism for liver and tumor segmentation.Scientific reports · 2025Article
- Automatic computed tomography image segmentation method for liver tumor based on a modified tokenized multilayer perceptron and attention mechanism.Quantitative imaging in medicine and surgery · 2025Article
- Article
- Clinical evaluation of the convolutional neural network‑based automatic delineation tool in determining the clinical target volume and organs at risk in rectal cancer radiotherapy.Oncology letters · 2024Article
- A Review of Advancements and Challenges in Liver Segmentation.Journal of imaging · 2024Review
- Dual Attention-Based 3D U-Net Liver Segmentation Algorithm on CT Images.Bioengineering (Basel, Switzerland) · 2024Article
- Gaussian filter facilitated deep learning-based architecture for accurate and efficient liver tumor segmentation for radiation therapy.Frontiers in oncology · 2024Article
- Real-Time Reconstruction of HIFU Focal Temperature Field Based on Deep Learning.BME frontiers · 2024Article
- Accurate and robust auto-segmentation of head and neck organ-at-risks based on a novel CNN fine-tuning workflow.Journal of applied clinical medical physics · 2024Article
- MANet: a multi-attention network for automatic liver tumor segmentation in computed tomography (CT) imaging.Scientific reports · 2023Article
- A Coarse-to-Fine Fusion Network for Small Liver Tumor Detection and Segmentation: A Real-World Study.Diagnostics (Basel, Switzerland) · 2023Article
- RETRACTED: Liver Tumor Localization Based on YOLOv3 and 3D-Semantic Segmentation Using Deep Neural Networks.Diagnostics (Basel, Switzerland) · 2022Article
- A Review of Artificial Intelligence Application for Radiotherapy.Dose-response : a publication of International Hormesis SocietyReview
- Machine Learning-Based Quality Assurance for Automatic Segmentation of Head-and-Neck Organs-at-Risk in Radiotherapy.Technology in cancer research & treatmentArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAccurate segmentation of liver and liver tumors is critical for radiotherapy. Liver tumor segmentation, however, remains a difficult and relevant problem in the field of medical image processing because of the various factors like complex and variable location, size, and shape of liver tumors, low contrast between tumors and normal tissues, and blurred or difficult-to-define lesion boundaries. In this paper, we proposed a neural network (S-Net) that can incorporate attention mechanisms to end-to-end segmentation of liver tumors from CT images.
methodsFirst, this study adopted a classical coding-decoding structure to realize end-to-end segmentation. Next, we introduced an attention mechanism between the contraction path and the expansion path so that the network could encode a longer range of semantic information in the local features and find the corresponding relationship between different channels. Then, we introduced long-hop connections between the layers of the contraction path and the expansion path, so that the semantic information extracted in both paths could be fused. Finally, the application of closed operation was used to dissipate the narrow interruptions and long, thin divide. This eliminated small cavities and produced a noise reduction effect.
resultsIn this paper, we used the MICCAI 2017 liver tumor segmentation (LiTS) challenge dataset, 3DIRCADb dataset and doctors' manual contours of Hubei Cancer Hospital dataset to test the network architecture. We calculated the Dice Global (DG) score, Dice per Case (DC) score, volumetric overlap error (VOE), average symmetric surface distance (ASSD), and root mean square error (RMSE) to evaluate the accuracy of the architecture for liver tumor segmentation. The segmentation DG for tumor was found to be 0.7555, DC was 0.613, VOE was 0.413, ASSD was 1.186 and RMSE was 1.804. For a small tumor, DG was 0.3246 and DC was 0.3082. For a large tumor, DG was 0.7819 and DC was 0.7632.
conclusionS-Net obtained more semantic information with the introduction of an attention mechanism and long jump connection. Experimental results showed that this method effectively improved the effect of tumor recognition in CT images and could be applied to assist doctors in clinical treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.